SOLIDWORKS

Computer-Aided Engineering Market - 39% of Growth to Originate from APAC| Evolving Opportunities with Altair Engineering Inc. and ANSYS Inc. | 17000 + Technavio Reports

Retrieved on: 
Tuesday, February 22, 2022
Automotive industry, Computer-aided design, Segment, DELMIA, Growth, OMNIS, Multiphysics, Awareness, CAE, Ansys, Defense, SOLIDWORKS, Intelligence, CAD, Industry, SIMULIA, Electronics, Electricity, Computer-aided engineering, By-product, FEA, USD, MEA, CATIA, Revenue, Virtual reality, Marketing, Engineering, CAGR, CFD, ESI Group, Software, TOC, Retail, 3D printing, Asset management, Casino, GEOVIA, ENOVIA, Geography, BIOVIA

Market growth in APAC will be fasterthan the growth of the market in other regions.

Key Points: 
  • Market growth in APAC will be fasterthan the growth of the market in other regions.
  • https://www.technavio.com/report/report/computer-aided-engineering-marke...
    The computer-aided engineering market is driven by the growth of the smartphone industry.
  • Computer-Aided Design Market -The projected valuation of the computer-aided design (CAD) market by 2025 is USD3.28 billion.
  • The growth momentum of the market is expected to accelerate at a CAGR of 6.41%, during 2021-2025.

Medidata Opens Access to its Patient Insights Program, Enabling Sponsors and CROs to Leverage Proprietary Patient Centricity by Design Process for Clinical Trials

Retrieved on: 
Tuesday, February 15, 2022
Biotechnology, Health, Other Health, Program, Patient, Learning, Design, Risk, IMPACT, Cros, Euronext Paris, Hope, Clinical trial, SIMULIA, DELMIA, CATIA, Dassault Group, Patient engagement in Canada, 3D, Research, SOLIDWORKS, McKinney–Vento Homeless Assistance Act, Pharmaceutical industry, Medical device, GEOVIA, ENOVIA, Medidata Solutions, BIOVIA, Compass, Medidata, Dassault Systèmes, MEDIDATA, DASSAULT SYSTèMES

Medidata , a Dassault Systmes company, today announced it is allowing sponsors, CROs (contract research organizations), and sites to leverage its proprietary Patient Centricity by Design process for clinical trials.

Key Points: 
  • Medidata , a Dassault Systmes company, today announced it is allowing sponsors, CROs (contract research organizations), and sites to leverage its proprietary Patient Centricity by Design process for clinical trials.
  • Medidata will open access to its Patient Insights Program as part of a new offering to incorporate a patient-centric approach to the design and development of clinical trial protocols and technologies.
  • We are opening up access to this program to ultimately make clinical trials an option for more people, including those historically left behind by clinical trials.
  • The Medidata Patient Insights team has run over 20 design studios to provide feedback and insights into Medidata's products.

Dassault Systèmes Taps Gian Paolo Bassi to Lead 3DEXPERIENCE Works; Promotes Manish Kumar to CEO SOLIDWORKS

Retrieved on: 
Monday, February 7, 2022
Software, Technology, Electronic Design Automation, Data Management, DELMIA, Growth, Product lifecycle, Research, Solution, CATIA, Technology, Euronext Paris, Warner Bros. Global Brands and Franchises, SIMULIA, Dassault Group, Â, Learning, CEO, Adoption, DSY, 3D, PLM, CAD, Ecosystem, Development, SOLIDWORKS, Management, Renewable energy, Video game, 3D printing, BIOVIA, Compass, GEOVIA, ENOVIA

Gian Paolo Bassi, the successful seven-year CEO of SOLIDWORKS, will lead Dassault Systmes 3DEXPERIENCE Works organization as Executive Vice President.

Key Points: 
  • Gian Paolo Bassi, the successful seven-year CEO of SOLIDWORKS, will lead Dassault Systmes 3DEXPERIENCE Works organization as Executive Vice President.
  • Manish Kumar, in charge of SOLIDWORKS R&D since 2018, adds CEO of SOLIDWORKS to his responsibilities.
  • The appointment of Gian Paolo Bassi follows Dassault Systmes successful creation of 3DEXPERIENCE Works in 2019 as a portfolio of cloud solutions on the 3DEXPERIENCE platform that is tailored for SOLIDWORKS customers and all mid-market companies and their ecosystem.
  • Dassault Systmes 3DEXPERIENCE platform, 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions: http://www.3ds.com
    News from 3DEXPERIENCE World 2022: @Dassault3DS taps Gian Paolo Bassi to lead #3DEXPERIENCE Works; promotes Manish Kumar to CEO #SOLIDWORKS
    Dassault Systmes, the 3DEXPERIENCE Company, is a catalyst for human progress.

Parexel Extends Strategic Partnership with Medidata to Enhance Delivery of Decentralized Clinical Trials

Retrieved on: 
Friday, February 4, 2022
Research, Technology, Other Technology, Clinical Trials, Biotechnology, General Health, Pharmaceutical, Health, Science, Other Science, Cloud, Risk, Patient, Learning, Clinical trial, Design, DELMIA, Dassault Group, Euronext Paris, 3D, SIMULIA, Research, COVID-19, Partnership, Parexel, SOLIDWORKS, DCT, Health, CRO, Industry, CATIA, Pharmaceutical industry, GEOVIA, ENOVIA, Compass, BIOVIA, Medidata Solutions, Medidata, Dassault Systèmes, MEDIDATA, DASSAULT SYSTèMES

Medidata , a Dassault Systmes company, announced today that Parexel , a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health, is extending their 15-year global strategic partnership.

Key Points: 
  • Medidata , a Dassault Systmes company, announced today that Parexel , a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health, is extending their 15-year global strategic partnership.
  • Parexels priority focus is on providing patient-centered solutions that enhance the clinical trial experience and make participation more accessible to everyone, said Clare Grace, Ph.D., Chief Patient Officer at Parexel.
  • Medidatas DCT technologies further support our efforts in a market where nearly 75% of proposals include at least a hybrid trial model.
  • Anthony Costello, Patient Cloud CEO at Medidata, added: The COVID-19 pandemic showed us that we can leverage DCT technologies to expedite and enhance the entire clinical trials process.

Medidata Experts Address Operationalizing Decentralized Clinical Trials and AI Predictive Models at SCOPE Conference

Retrieved on: 
Thursday, February 3, 2022
Technology, Clinical Trials, Software, Biotechnology, Training, Health, Pharmaceutical, General Health, Education, Cloud, Risk, Patient, Partnership, Learning, Key, PPD, Summit, SCOPE, Disease, Clinical trial, AI, DELMIA, Dassault Group, Euronext Paris, 3D, SIMULIA, Forecasting, Technology, Research, Data science, Â, DCT, SOLIDWORKS, SVP, Thermo Fisher Scientific, VP, Industry, Digital, DCTS, CATIA, Pharmaceutical industry, Medical imaging, Music, Television, GEOVIA, ENOVIA, Compass, BIOVIA, Medidata Solutions, Medidata, Dassault Systèmes, MEDIDATA, DASSAULT SYSTèMES

Medidata , a Dassault Systmes company, will be sharing insights into new decentralized clinical trials (DCTs) and AI technologies as a signature sponsor of the annual Summit for Clinical Ops Executives (SCOPE), February 7-10.

Key Points: 
  • Medidata , a Dassault Systmes company, will be sharing insights into new decentralized clinical trials (DCTs) and AI technologies as a signature sponsor of the annual Summit for Clinical Ops Executives (SCOPE), February 7-10.
  • Medidata experts will be participating in multiple presentations covering a range of innovative solutions to advance clinical trial planning, management, and operations.
  • Digital capabilities including centralized monitoring, electronic patient-reported outcomes, and wearable sensors are enabling clinical trial decentralization at scale.
  • This session explores how DCTs have evolved and elevated RBQM (risk-based quality management) strategies towards the new normal for clinical operations.

Inria and Dassault Systèmes Form Strategic Alliance for a European Digital Trusted Platform

Retrieved on: 
Thursday, February 3, 2022
Electronic Design Automation, Other Professional Services, Data Management, Manufacturing, Consumer Electronics, Other Health, Technology, Professional Services, General Health, Biotechnology, Software, Networks, Internet, Health, Engineering, CEO, Leadership, DNA, Solution, Patient, Learning, Organization, DELMIA, Dassault Group, Trust, Digital technology, Euronext Paris, 3D, SIMULIA, Technology, COVID-19, Research, Digital Science, Drug discovery, SOLIDWORKS, Health, Science, PLM, Industry, Directorate, Hospital, Product lifecycle, CATIA, Weapon, Management, GEOVIA, French Institute for Research in Computer Science and Automation, ENOVIA, Compass, BIOVIA

Dassault Systmes (Euronext Paris: FR0014003TT8, DSY.PA) (Paris:DSY)and Inria , Frances National Institute for Research in Digital Science and Technology, today announced a strategic alliance for European digital sovereignty.

Key Points: 
  • Dassault Systmes (Euronext Paris: FR0014003TT8, DSY.PA) (Paris:DSY)and Inria , Frances National Institute for Research in Digital Science and Technology, today announced a strategic alliance for European digital sovereignty.
  • The alliance between Inria and Dassault Systmes marks the next step in strengthening their 20-year collaboration dedicated to critical advances in digital technology and science.
  • This strategic alliance with world leader Dassault Systmes is part of an action plan to strengthen the digital power of France and Europe.
  • Dassault Systmes 3DEXPERIENCE platform, 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions: http://www.3ds.com
    Inria is the French national research institute for digital science and technology.

Dassault Systèmes Announces Executive Committee Evolutions

Retrieved on: 
Thursday, February 3, 2022
Electronic Design Automation, Professional Services, Data Management, Technology, Human Resources, Software, Finance, Growth, Leadership, Solution, Learning, Health care, NASDAQ, Manufacturing, University, Operation, Executive Committee, Â, Richard Barker (life sciences and healthcare leader), CFO, DELMIA, Dassault Group, Nature, Product lifecycle, Euronext Paris, 3D, SIMULIA, Doctor of Philosophy, Bergmann, National Executive Committee of the Labour Party, List of life sciences, SOLIDWORKS, Institute of technology, Acquisition, PLM, Infrastructure, Technical University of Kaiserslautern, City, Compass, Medidata Solutions, SAP, Economics, Software, Technical University of Munich, CATIA, Management, BIOVIA, GEOVIA, ENOVIA

He has a faultless mastery of financial matters related to software and the cloud, and he has played an important role in the integration of MEDIDATA after its acquisition by Dassault Systmes.

Key Points: 
  • He has a faultless mastery of financial matters related to software and the cloud, and he has played an important role in the integration of MEDIDATA after its acquisition by Dassault Systmes.
  • He was previously COO Life Sciences for Dassault Systmes, overseeing MEDIDATAs operations.
  • Dassault Systmes 3DEXPERIENCE platform, 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions: http://www.3ds.com
    Dassault Systmes, the 3DEXPERIENCE Company, is a catalyst for human progress.
  • Dassault Systmes brings value to more than 290,000 customers of all sizes, in all industries, in more than 140 countries.

Sigmetrix To Sponsor Dassault Systèmes' 3DEXPERIENCE World 2022

Retrieved on: 
Tuesday, February 1, 2022
GD, Gold, MBE, Name, Engineering, Creativity, Technology, Efficiency, Pressure, SOLIDWORKS, Time, Ecosystem, Solution, MBD, Risk management

MCKINNEY, Texas, Feb. 1, 2022 /PRNewswire-PRWeb/ -- Sigmetrix, experts in mechanical variation management, will sponsor Dassault Systmes' 3DEXPERIENCE World 2022 being held virtually February 7-9, 2022.

Key Points: 
  • MCKINNEY, Texas, Feb. 1, 2022 /PRNewswire-PRWeb/ -- Sigmetrix, experts in mechanical variation management, will sponsor Dassault Systmes' 3DEXPERIENCE World 2022 being held virtually February 7-9, 2022.
  • Ignoring mechanical variation during the initial design activities usually causes multiple iterative design loops as problems are uncovered during validation, prototype, and pilot stages.
  • "We are thrilled to be sponsoring 3DEXPERIENCE World again this year.
  • 3DEXPERIENCE World brings together designers, engineers, managers, and partners to discuss ideas, trends, and the technology shaping the future of product design.

Medidata Expands and Strengthens Decentralized Clinical Trial (DCT) Capabilities Through Groundbreaking Partnership With Circuit Clinical

Retrieved on: 
Wednesday, January 26, 2022
Software, Research, Other Health, General Health, Mobile, Wireless, Internet, Data Management, Technology, Clinical Trials, Science, Other Technology, Health, Other Science, Cloud, Board of directors, COVID-19, Database, Overalls, Risk, IRO, Dassault Group, Awareness, Degenerative disease, SIMULIA, Diabetes, Patient, Cros, Twitter, 3D, Board, Cardiovascular disease, Research, Cancer, DELMIA, DCTS, Instagram, CATIA, SOLIDWORKS, Clinical trial, LinkedIn, Solution, DCT, Rheumatoid arthritis, Euronext Paris, Learning, Kidney disease, Physician, CEO, Partnership, Pharmaceutical industry, BIOVIA, Compass, Medidata Solutions, ENOVIA, Facebook, GEOVIA, MD, Medidata, Dassault Systèmes, Circuit Clinical, MEDIDATA, DASSAULT SYSTèMES, CIRCUIT CLINICAL

Medidata , a Dassault Systmes company, today announced a groundbreaking and exclusive partnership with Circuit Clinical, an Integrated Research Organization (IRO).

Key Points: 
  • Medidata , a Dassault Systmes company, today announced a groundbreaking and exclusive partnership with Circuit Clinical, an Integrated Research Organization (IRO).
  • Additionally, patients will have the opportunity to provide ratings and reviews of their clinical trial experiences through Circuit Clinicals award-winning TrialJourney system.
  • The combined capabilities of Circuit Clinical and Medidatas software solutions will further the ability to deliver hybrid or fully decentralized trials through Circuit Clinicals Network Health Systems and patient engagement capabilities.
  • Circuit Clinical is committed to transforming the way physicians and their patients find, choose, and participate in clinical research.

GoEngineer Completes Recapitalization with Court Square Capital Partners

Retrieved on: 
Thursday, January 13, 2022
Professional Services, Data Management, Technology, Finance, Software, Banking, Court Square Capital Partners, Technology, Stratasys, Health, CAD, PLM, Court Square, Growth, SOLIDWORKS, Dechert, CEO, Solution, Leadership, Lazard, Acceleration, Industry, Company, 3D, Software, Engineering, Investment, Ametek

GoEngineer (the Company), a leading provider of 3D design and additive manufacturing solutions, is pleased to announce that it has finalized a majority recapitalization of the business with Court Square Capital Partners (Court Square).

Key Points: 
  • GoEngineer (the Company), a leading provider of 3D design and additive manufacturing solutions, is pleased to announce that it has finalized a majority recapitalization of the business with Court Square Capital Partners (Court Square).
  • Ken Coburn, Founder and CEO of GoEngineer, will continue to lead the business alongside the Companys existing management team and will remain a significant investor alongside Court Square.
  • Court Square is excited about the opportunity to partner with the management team at GoEngineer, and we are strong believers in the continued growth of the CAD and 3D printing markets, said Jeff Vogel, Managing Partner at Court Square.
  • Court Square has $7.5 billion of assets under management and is based in New York, N.Y. For more information on Court Square, please visit www.courtsquare.com .